TITLE

The Industry

PUB. DATE
May 2007
SOURCE
Pharmaceutical Representative;May2007, Vol. 37 Issue 5, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to pharmaceutical industry. Bayer HealthCare in Berlin will layoff 6,100 jobs worldwide as it incorporates with Schering AG. Abbott Laboratories Inc. in Illinois has cut down its sales force by 700 positions. Schering-Plough Corp. in New Jersey has united to acquire Organon BioSciences for about $14.4 billion including Roseland, New Jersey-based Organon USA.
ACCESSION #
24946530

 

Related Articles

  • Dollar Buoys Foreign M&As. Gaudio, Thomas // njbiz;6/16/2008, Vol. 21 Issue 25, p17 

    The article reports on the increase the U.S. dollar volume of foreign mergers and acquisitions among pharmaceutical firms. It notes that the volume experienced an almost 43% increase in 2007 as foreign firms acquired U.S. counterparts at discount prices. It adds that the weak dollar and strong...

  • Schering-Plough taps into Organon. Mirasol, Feliza // ICIS Chemical Business Americas;3/26/2007, Vol. 271 Issue 12, p26 

    The article focuses on the planned acquisition of Organon BioSciences by Schering-Plough, which will boost the latter's presence in the therapeutic categories of women's health and central nervous system (CNS) disorders. The move is part of the turnaround strategy of president and chief...

  • Schering Goes Dutch.  // njbiz;3/19/2007, Vol. 20 Issue 12, p2 

    The article reports on a deal entered into by drug maker Schering-Plough Corp. to acquire Organon BioSciences, the health care unit of Akzo Novel N.V., for about $14.4 billion. Heather Brilliant, an analyst with independent investment research firm Morningstar, questions the value of the deal in...

  • SCHERING-PLOUGH CORP.  // MondayMorning;2/9/2009, Vol. 17 Issue 5, p1 

    The article reports on the financial performance of Kenilworth, New Jersey-based company Schering-Plough Corp. for the fourth quarter of 2008. The company reported higher-than-expected quarterly earnings due to cost-cutting. It states that the firm planned to cut 20% of its U.S. sales force to...

  • Schering-Plough's integration of Organon lifts Q3 results.  // PharmaWatch: Monthly Review;Dec2008, Vol. 7 Issue 12, p26 

    The article reports on the advantage of the acquisition of Organon Bioscience by Schering-Plough to the company's global revenues. As a result to the acquisition, Schering-Plough has posted positive results for the third quarter of 2008, despite setbacks it faced. Moreover, the company's efforts...

  • Schering-Plough acquires Organon BioSciences.  // PharmaWatch: Biotechnology;Jan2008, Vol. 7 Issue 1, p18 

    The article reports on the acquisition of Organon BioSciences by Schering-Plough Corp. from Akzo Nobel for 11 billion euros. The acquisition forms a stronger combined company with a wide range of human and animal health portfolios, and develops an area for increased research and development...

  • Cuts by Company.  // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p158 

    A list of U.S. pharmaceutical companies which made retrenchment in their employees in 2007. One of these companies is Pfizer Inc. with total job cuts of 10,000, with percentage workforce of 10% and with annual savings of $2 billion. Another one is Abbott Laboratories Inc. with total job cuts of...

  • Pharma troubles are bitter pill. Williams, Dede // ICIS Chemical Business;3/17/2008, Vol. 273 Issue 11, p12 

    The article presents information on several problems faced by Bayer AG, a pharmaceutical firm headquartered in Leverkusen, Germany. It states that even though the firm seems to have revitalized its healthcare franchise Bayer HealthCare AG with the acquisition of pharma research firm Schering AG...

  • Leading Indicators.  // Pharmaceutical Executive;Apr2007, Vol. 27 Issue 4, p19 

    The article focuses on several pharmacy-related issues in the U.S. The Schering-Plough Corp. has acquired the Organon Biosciences NV to expand its primary care and hospital markets. The Merck & Co. Inc.'s Human papillomavirus (HPV) vaccine Gardasil has been required to prevent the prevalence of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics